Our company news

Smooth Drug Development achievements in China

Published on Friday January 27, 2023

Smooth Drug Development achievements in China Smooth Drug Development opened a representative office in China and plans to continue its contribution to the development of therapeutics in China and assist Chinese clients enter EAEU and EC markets

Read more →

Smooth Drug Development December 2022 News Release

Published on Friday January 06, 2023

We are working on the following new projects: • We were awarded with a bioequivalence trial of Ketorolac.

Read more →

Smooth Drug Development November 2022 News Release

Published on Tuesday December 06, 2022

We are working on the following new projects: • We signed the contract for the trial of III phase in inflammatory and degenerative diseases of the musculoskeletal system.

Read more →

Smooth Drug Development October 2022 News Release

Published on Sunday November 06, 2022

We are working on the following new projects: We signed the contracts for the III phase Nimesulide trials of in dorsopathy and postoperative pain.

Read more →

Smooth Drug Development September 2022 News Release

Published on Thursday October 06, 2022

We are working on the following new projects: • We signed a contract for medical writing activities with Fabomotizole.

Read more →

Smooth Drug Development Conference: Global Expansion and Exit Strategies for Chinese Healthcare Companies

Published on Tuesday October 04, 2022

Read more →

Smooth Drug Development August 2022 News Release

Published on Saturday August 06, 2022

We are working on the following new projects: • We were awarded with a contract for medical writing activities with pelubiprofen

Read more →

Smooth Drug Development July 2022 News Release

Published on Saturday August 06, 2022

We are working on the following new projects: • We were awarded with two contracts for full-service support in bioequivalence trials with Rivaroxaban 10 mg and 20 mg.

Read more →

Smooth Drug Development June 2022 News Release

Published on Wednesday July 06, 2022

We are working on the following new projects: • We signed two contracts for data management services for bioequivalence trials with Paroxetine and Desloratadine.

Read more →

Smooth Drug Development May 2022 News Release

Published on Monday June 06, 2022

We are working on the following new projects: Smooth signed a contract for a bioequivalence trial with Rivaroxaban.

Read more →

CLINICAL TRIALS DAY

Published on Friday May 20, 2022

The International Day of Clinical Research is celebrated on May 20

Read more →

Smooth Drug Development April 2022 News Release

Published on Friday May 06, 2022

We are working on the following new projects: • Smooth is starting a new project in acute nasopharyngitis with our long-term Russian client.

Read more →

Smooth Drug Development March 2022 News Release

Published on Wednesday April 06, 2022

We are working on the following new projects: • We were awarded with Rebamipide trial.

Read more →

Smooth Drug Development February 2022 News Release

Published on Sunday March 06, 2022

We are working on the following new projects: Smooth signed a contract for a trial with Fabomotizole. We were awarded with a medical writing project with INN Budesonide.

Read more →

Smooth Drug Development January 2022 News Release

Published on Sunday February 06, 2022

We are working on the following new projects: • We were awarded with two phase IV full-service trials of Nimesulide. • We signed four new contracts for BE trials with our Russian sponsor

Read more →